flaviviru
envelop
protein
locat
outermost
surfac
viral
particl
mediat
viru
entri
fusion
infect
domain
ii
e
protein
play
import
role
process
studi
express
purifi
goos
tembusu
viru
gtv
e
protein
domain
ii
diii
e
coli
test
conceptu
approach
purifi
protein
serv
antivir
reagent
found
diii
inhibit
gtv
infect
cell
dosedepend
manner
inhibit
activ
achiev
bind
cell
membran
specif
moreov
treat
diii
specif
antiserum
decreas
infect
cell
taken
togeth
first
show
purifi
di
ii
domain
tembusu
viru
express
e
coli
abl
interfer
viru
infect
open
avenu
develop
novel
antivir
regent
prevent
eventu
erad
gtv
infect
april
sever
diseas
spread
duckand
goosefarm
region
china
includ
zhejiang
jiangsu
fujian
provinc
diseas
continu
spread
winter
shelduck
gees
provinc
shandong
henan
hunan
hubei
jiangxi
huge
threat
pathogen
affect
egglay
duck
show
reduct
egg
product
clinic
sign
includ
acut
anorexia
antisoci
behavior
rhinorrhea
diarrhea
ataxia
paralysi
morbid
mortal
possibl
due
secondari
bacteri
infect
yan
et
al
recent
studi
indic
domest
chicken
suscept
emerg
diseas
similar
clinic
sign
cao
et
al
liu
et
al
liu
et
al
su
et
al
tang
et
al
new
diseas
becom
one
econom
import
infecti
diseas
duck
china
laboratori
field
investig
determin
goos
egg
drop
syndrom
caus
new
flaviviru
name
viru
close
relat
tembusu
viru
flavivirus
singlestrand
positivesens
rna
virus
classifi
genu
flaviviru
hoshino
et
al
flaviviru
genu
famili
flavivirida
consist
nearli
virus
mani
japanes
enceph
viru
yellow
fever
viru
west
nile
viru
tickborn
enceph
viru
lead
sign
mild
febril
diseas
enceph
hemorrhag
fever
shock
syndrom
death
human
anim
brault
et
al
flaviviru
genom
approxim
kb
contain
one
singl
open
read
frame
orf
encod
polyprotein
zou
et
al
polyprotein
cleav
three
structur
protein
capsid
c
membran
envelop
e
seven
nonstructur
protein
viral
cellular
proteas
nonstructur
protein
respons
viru
replic
proteolysi
matur
lindenbach
rice
mukhopadhyay
et
al
major
envelop
protein
e
flaviviru
receptor
bind
protein
primari
determin
host
rang
cell
tropism
virul
major
antigen
elicit
neutral
antibodi
immun
respons
chu
et
al
roehrig
addit
e
protein
mediat
viru
host
membran
fusion
acid
milieu
late
endosom
chu
ng
heinz
allison
e
protein
consist
three
domain
structur
central
amino
termin
domain
domain
di
dimer
domain
domain
ii
dii
carboxyl
termin
iglik
domain
domain
iii
diii
rey
et
al
central
unit
e
protein
complex
di
adopt
structur
act
bridgelik
hing
link
extend
dii
globular
diii
togeth
histidin
hing
region
import
trigger
conform
chang
dii
diii
upon
ph
chang
process
viral
cell
membran
fusion
homodim
formationdissoci
dii
compos
two
segment
project
loop
di
larg
segment
dii
compos
twist
strand
stabil
disulfid
bond
contain
highli
conserv
hydrophob
fusion
loop
tip
known
fusion
peptid
fp
fp
respons
direct
interact
target
membran
fusogen
conform
achiev
mend
et
al
yu
et
al
diii
locat
cterminu
e
protein
contain
sever
epitop
elicit
virusneutr
antibodi
chu
et
al
addit
studi
shown
diii
mediat
flaviviru
attach
host
cell
anderson
sinc
domain
ii
play
import
role
flaviviru
entri
attract
target
block
infect
present
studi
domain
ii
goos
tembusu
viru
clone
express
refold
purifi
recombin
protein
diii
test
competit
inhibit
goos
tembusu
viru
entri
cell
maintain
dmem
contain
inactiv
fetal
calf
serum
fc
plu
penicillinstreptomycin
cell
grown
atmospher
goos
tembusu
viru
gtv
isol
affect
goos
neurolog
clinic
sign
propag
cell
use
studi
cell
cultur
demonstr
cpe
cell
round
float
free
surfac
flask
cultur
collect
stock
viru
store
use
serial
dilut
stock
viru
use
determin
tissu
cultur
infect
dose
dilut
inocul
monolay
viru
allow
attach
cell
monolay
h
remov
prior
cover
mixtur
agaros
cell
cultur
media
cell
observ
daili
plaqu
product
four
day
calcul
accord
reedmuench
method
reed
muench
monoclon
antibodi
e
protein
produc
lab
antiflag
tag
monoclon
antibodi
alkalin
phosphataseconjug
goat
antimous
igg
purchas
beyotim
institut
biotechnolog
diii
entir
e
gene
clone
vector
frame
flag
result
plasmid
transform
respect
protein
express
e
coli
strain
purifi
antiflag
affin
gel
accord
manufactur
instruct
sigma
gene
fragment
ntermin
aa
di
dii
e
protein
amplifi
pcr
use
follow
primer
forward
primer
revers
primer
ecor
sal
restrict
site
underlin
sequenc
flag
tag
dykddddk
italic
pcr
product
bp
digest
restrict
enzym
ecor
sal
ligat
vector
digest
restrict
enzym
result
construct
design
confirm
dna
sequenc
transform
grown
lb
shake
cultur
reach
iptg
ad
final
concentr
mm
addit
h
cell
harvest
centrifug
g
min
wash
three
time
pb
buffer
cell
resuspend
pb
buffer
lyse
ultrason
cell
disruptor
follow
centrifug
g
min
protein
express
confirm
run
crude
lysat
sdspolyacrylamid
gel
visual
coomassi
stain
inclus
bodi
solubil
urea
protein
purifi
antiflag
affin
gel
follow
instruct
sigma
compani
puriti
purifi
protein
examin
sdspage
confirm
western
blot
antiflag
antibodi
beyotim
anti
monoclon
antibodi
describ
seventi
microgram
diii
mix
equal
volum
freund
complet
adjuv
sigma
antigenadjuv
mixtur
appli
femal
balbc
mice
three
time
subcutan
interv
mous
sera
collect
day
last
booster
store
titer
polyclon
antiserum
assess
indirect
enzym
link
immunoassay
elisa
establish
purifi
protein
diii
captur
antigen
hrpconjug
goatantimous
igg
use
detect
antibodi
respect
differ
dilut
polyclon
antiserum
use
measur
titer
polyclon
antiserum
indirect
elisa
differ
concentr
diii
bsa
diii
e
protein
ad
cell
cell
incub
h
unbound
protein
remov
wash
cell
three
time
pb
cell
infect
gtv
h
unbound
viru
remov
wash
three
time
pb
total
rna
extract
infect
cell
axyprep
bodi
fluid
viral
dnarna
miniprep
kit
axygen
viru
nucleic
acid
detect
revers
transcriptas
realtim
pcr
assay
examin
viru
entri
primer
use
realtim
pcr
ef
primer
forward
er
primer
revers
three
independ
experi
carri
cell
grown
glass
coverslip
plate
incub
purifi
protein
diii
diii
e
bsa
h
unbound
protein
remov
wash
cell
three
time
pb
cell
fix
paraformaldehyd
permeabil
triton
block
bsa
pb
cell
incub
mous
antiflag
antibodi
beyotim
follow
incub
fitc
conjug
goat
antimous
igg
antibodi
cell
examin
fluoresc
microscop
evalu
neutral
abil
antiserum
mice
immun
protein
diii
viru
plaqu
reduct
assay
perform
antiserum
dilut
serial
twofold
dmem
dilut
mix
viru
incub
h
residu
infect
viru
determin
plaqu
assay
describ
determin
whether
protein
diii
toxic
cell
cell
mitochondri
reductas
activ
measur
addit
protein
cell
count
dojindo
accord
manufactur
protocol
briefli
diii
diii
e
bsa
serumfre
dmem
ad
monolay
plate
h
incub
h
ad
well
incub
h
absorb
nm
measur
use
biotek
micropl
reader
clone
ntermin
part
amino
acid
envelop
e
protein
frame
flag
tag
express
vector
part
e
contain
domain
ii
transform
construct
e
coli
strain
induc
addit
mm
iptg
kda
protein
readili
induc
appar
visual
crude
cell
lysat
separ
sdspage
gel
follow
coomassi
stain
fig
lane
near
ident
protein
similar
molecular
weight
purifi
affin
purif
antiflag
tag
antibodi
fig
importantli
purifi
protein
recogn
anti
monoclon
antibodi
antiflag
antibodi
confirm
immunoblot
assay
fig
domain
ii
envelop
protein
e
gtv
propos
import
role
viru
entri
test
truncat
e
protein
contain
domain
ii
compet
endogen
e
mediat
viru
entri
perform
viru
entri
assay
examin
viral
rna
level
insid
cell
realtim
pcr
describ
section
materi
method
shown
fig
bsa
diii
treat
cell
suggest
viru
entri
cell
inhibit
protein
diii
dosedepend
manner
pretreat
concentr
recombin
diii
protein
result
inhibit
gtv
entri
given
diii
inhibit
entri
cell
set
investig
mechan
inhibit
want
know
diii
bind
cell
membran
bind
block
e
protein
access
cell
membran
ad
purifi
diii
monolay
incub
cell
h
wash
excess
protein
pb
follow
indirect
immunofluoresc
assay
specif
antibodi
examin
whether
diii
detect
shown
fig
specif
fluoresc
cell
membran
observ
diii
treat
cell
panel
c
bsaor
diiitreat
cell
panel
b
result
suggest
ntermin
part
e
protein
contain
domain
ii
suffici
bind
cell
membran
verifi
specif
diii
block
viru
entri
perform
plaqu
neutral
assay
use
antidiii
specif
serum
murin
polyclon
antibodi
diii
produc
titer
antiserum
assess
indirect
elisa
establish
purifi
diii
captur
antigen
data
shown
plaqu
neutral
assay
carri
describ
materi
method
shown
fig
viru
titer
lower
dilut
dilut
antiserumtr
cell
decreas
compar
preimmun
serumtr
cell
conclud
diii
specif
antiserum
neutral
viru
neutral
viru
maintain
murin
polyclon
antibodi
dilut
greater
dilut
exponenti
decreas
degre
neutral
howev
dilut
factor
neutral
viru
result
conclud
diii
specif
antiserum
neutral
infect
order
make
sure
inhibit
recombin
diii
protein
due
underli
cytox
test
whether
purifi
protein
diii
toxic
cell
monolay
expos
concentr
diii
h
cell
viabil
evalu
measur
mitochondri
reductas
activ
shown
fig
significantli
differ
viabl
cell
number
among
treatment
even
presenc
protein
suggest
diii
nontox
cell
outbreak
rapid
spread
egg
drop
syndrom
major
duckgooseproduc
region
china
result
seriou
econom
loss
despit
inactiv
live
attenu
vaccin
evalu
duck
model
li
et
al
risk
antibodi
depend
enhanc
inactiv
viru
safeti
concern
live
viru
vaccin
highli
debat
chu
et
al
jiang
et
al
demonstr
synthet
peptid
correspond
sequenc
glycoprotein
could
block
viru
infect
subsequ
addit
peptid
mimic
fusion
protein
retrovirus
orthomyxovirus
paramyxovirus
filovirus
coronavirus
herpesvirus
also
identifi
shown
inhibit
viral
entri
synthet
peptid
correspond
sequenc
domain
ii
iii
stem
dengu
viru
west
nile
viru
e
protein
identifi
inhibit
infect
virus
hrobowski
et
al
studi
show
first
time
gtv
e
truncat
protein
diii
suffici
inhibit
infect
inhibitori
effect
diii
dose
depend
rang
fig
note
inhibit
activ
diii
higher
e
protein
p
possibl
e
protein
ctermin
truncat
bind
cell
membran
better
first
step
flavivirus
enter
cell
involv
bind
e
protein
cell
receptor
smit
et
al
flavivirus
must
recogn
ubiquit
cell
surfac
molecul
util
multipl
receptor
cell
entri
rodenhuiszybert
et
al
e
protein
initi
postul
form
receptor
bind
site
viru
particl
expos
locat
surfac
viru
chu
et
al
crystallograph
studi
denvdcsign
complex
reveal
interact
dcsign
preferenti
mediat
dii
smit
et
al
studi
provid
direct
evid
first
time
diii
gtv
e
protein
involv
bind
cell
surfac
molecul
cell
fig
know
exact
mechan
diii
inhibit
infect
howev
result
suggest
diii
bind
cell
membran
bind
block
viru
access
cell
receptor
ongo
research
focu
conclus
find
excess
diii
protein
inhibit
gtv
infect
provid
novel
conceptu
target
design
antivir
agent
vaccin
prevent
eventu
erad
tembusu
viru
infect
